Mauna Kea Technologies
Paris
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product, Cellvizio®, has received clearance/approval for a wide range of applications in the United States and more than 40 countries around the World.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $76.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: epa:MKEA
- Website: maunakeatech.comen-gb
- Phone: +330148240345
Industries & Categories
Biotechnology, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/mauna-kea-technologies-55042 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.